Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
J Immunol. 2014 May 15;192(10):4560-4570. doi: 10.4049/jimmunol.1303461. Epub 2014 Apr 7.
Mesenchymal stem cells (MSCs) have been suggested to participate in immune regulation and airway repair/remodeling. TGF-β1 is critical in the recruitment of stem/progenitor cells for tissue repair, remodeling, and cell differentiation. In this study, we sought to investigate the role of TGF-β1 in MSC migration in allergic asthma. We examined nestin expression (a marker for MSCs) and TGF-β1 signaling activation in airways in cockroach allergen extract (CRE)-induced mouse models. Compared with control mice, there were increased nestin(+) cells in airways and higher levels of active TGF-β1 in serum and p-Smad2/3 expression in lungs of CRE-treated mice. Increased activation of TGF-β1 signaling was also found in CRE-treated MSCs. We then assessed MSC migration induced by conditioned medium from CRE-challenged human epithelium in air/liquid interface culture in Transwell assays. MSC migration was stimulated by epithelial-conditioned medium, but was significantly inhibited by either TGF-β1-neutralizing Ab or TβR1 inhibitor. Intriguingly, increased migration of MSCs from blood and bone marrow to the airway was also observed after systemic injection of GFP(+) MSCs and from bone marrow of Nes-GFP mice following CRE challenge. Furthermore, TGF-β1-neutralizing Ab inhibited the CRE-induced MSC recruitment, but promoted airway inflammation. Finally, we investigated the role of MSCs in modulating CRE-induced T cell response and found that MSCs significantly inhibited CRE-induced inflammatory cytokine secretion (IL-4, IL-13, IL-17, and IFN-γ) by CD4(+) T cells. These results suggest that TGF-β1 may be a key promigratory factor in recruiting MSCs to the airways in mouse models of asthma.
间质干细胞(MSCs)被认为参与免疫调节和气道修复/重塑。TGF-β1 对于招募干细胞/祖细胞进行组织修复、重塑和细胞分化至关重要。在这项研究中,我们试图研究 TGF-β1 在过敏性哮喘中 MSC 迁移中的作用。我们检查了蟑螂过敏原提取物(CRE)诱导的小鼠模型中气道中的巢蛋白表达(MSC 的标志物)和 TGF-β1 信号转导的激活。与对照小鼠相比,CRE 处理的小鼠气道中有更多的巢蛋白(+)细胞,血清中活性 TGF-β1 水平更高,肺中 p-Smad2/3 表达增加。在 CRE 处理的 MSC 中也发现 TGF-β1 信号转导的激活增加。然后,我们评估了在 Transwell 测定中在空气/液体界面培养的来自 CRE 挑战的人上皮的条件培养基诱导的 MSC 迁移。上皮条件培养基刺激 MSC 迁移,但 TGF-β1 中和 Ab 或 TβR1 抑制剂可显著抑制。有趣的是,在 GFP(+) MSC 全身注射后和在 CRE 挑战后 Nes-GFP 小鼠的骨髓中也观察到从血液和骨髓到气道的 MSC 迁移增加。此外,TGF-β1 中和 Ab 抑制了 CRE 诱导的 MSC 募集,但促进了气道炎症。最后,我们研究了 MSCs 在调节 CRE 诱导的 T 细胞反应中的作用,发现 MSCs 显著抑制了 CRE 诱导的 CD4(+) T 细胞中炎症细胞因子(IL-4、IL-13、IL-17 和 IFN-γ)的分泌。这些结果表明,TGF-β1 可能是招募 MSC 到哮喘小鼠模型气道中的关键趋化因子。